Divalproex Sodium Capsule, Coated Pellets
Product Images NDC 68382-106

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 68382-106). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

9d7218ee 8cd9 4fe2 Be42 9c9737af62ed 01

Chemical structure of divalproex sodium, depicting its molecular arrangement including sodium ions and organic groups. The structure shows a polymeric form with repeating units represented by 'n'.*

FDA Label Image

9d7218ee 8cd9 4fe2 Be42 9c9737af62ed 02

A line graph comparing the percentage reduction in CPS (clinical parameter score) rate between patients treated with divalproex sodium delayed-release tablets and placebo. The vertical axis shows percent reduction in CPS with improvement above and worsening below zero, while the horizontal axis represents percent of patients. The solid line represents divalproex sodium treatment and the dashed line represents placebo.*

FDA Label Image

9d7218ee 8cd9 4fe2 Be42 9c9737af62ed 03

A line graph showing the percentage reduction in CPS rate versus percentage of patients, comparing high dose and low dose groups. The vertical axis ranges from -100% to 100% indicating worsening to improvement. The horizontal axis represents the percentage of patients from 100% to 0%, with two lines: a solid line for high dose and a dashed line for low dose, illustrating changes in CPS rate outcomes.*

FDA Label Image

9d7218ee 8cd9 4fe2 Be42 9c9737af62ed 04

An instructional diagram showing four steps on how to handle and administer coated pellets inside a divalproex sodium capsule. The images depict careful capsule handling to prevent spilling, twisting the capsule open, placing the pellets onto a small amount of soft food, and swallowing the mixture immediately without chewing. Each step is accompanied by detailed text instructions to ensure proper use.*

FDA Label Image

9d7218ee 8cd9 4fe2 Be42 9c9737af62ed 05

Label for Divalproex Sodium Delayed-Release Capsules, USP 125 mg, coated pellets in capsule form. The label indicates the product contains 100 capsules and is for prescription use only. It is labeled by Zydus Pharmaceuticals USA Inc., distributed by Zydus Pharmaceuticals (USA) Inc., and manufactured by Cadila Healthcare Ltd. The label includes dosage information, storage instructions, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.